广康生化(300804.SZ)：多名股东拟合计减持不超过4.4592%股份

Group 1 - The core point of the article is that specific shareholders plan to reduce their holdings in Guangkang Biochemical (300804.SZ) within three months through centralized bidding and block trading [1] Group 2 - Shareholders Huatuo Zhiying No. 2 Investment Partnership and Huatuo Zhiyuan No. 3 Investment Enterprise plan to collectively reduce their holdings by no more than 1.3198 million shares, which is approximately 1.7835% of the company's total share capital [1] - Shareholder Ruihong Kaiyin No. 1 Equity Investment Fund Partnership plans to reduce its holdings by no more than 1.98 million shares, accounting for about 2.6757% of the company's total share capital [1]